Indegene

Indegene

Financials

Estimates*

Edit
Revenues, earnings & profits over time
INR202120222023
Revenues9.7b16.6b23.1b
% growth-72 %39 %
EBITDA2.6b3.1b4.4b
% EBITDA margin27 %18 %19 %
Profit1.5b1.6b2.7b
% profit margin15 %10 %12 %
  • Edit
DateInvestorsAmountRound

$200m

Valuation: $700m

Growth Equity VC
*

$6.5m

Valuation: $1.5b

6.6x EV/LTM Revenues

36.0x EV/LTM EBITDA

Secondary
*
N/A

N/A

IPO
Total FundingCAD273m

Recent News about Indegene

Edit
More about Indegene
Edit

We are a digital-first, life sciences commercialization company. We help biopharmaceutical, emerging biotech and medical device companies develop products, get them to the market, and grow their impact through the life cycle in a more effective, efficient, and modern way. We bring together healthcare domain expertise, fit-for-purpose technology, and an agile operating model to provide a diverse range of solutions. These aim to deliver, amongst other outcomes, a personalized, scalable and omnichannel experience for patients and physicians. It’s what drives our team and our purpose to enable healthcare organizations to be future ready.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Indegene

Edit
SKURA
ACQUISITION by Indegene Apr 2016
Encima Group
ACQUISITION by Indegene Dec 2016
Wincere
ACQUISITION by Indegene Dec 2016
Medical Marketing Economics
ACQUISITION by Indegene Aug 2021
MedCases
ACQUISITION by Indegene Nov 2006
Trilogy Writing & Consulting
ACQUISITION by Indegene Mar 2024
Cult Health
ACQUISITION by Indegene Oct 2022